Trial
NCT06483802
A Study of ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Astellas Gene Therapies
Collaborators
—
Condition
Friedreich Ataxia
Intervention
ASP2016
Why stopped
Corporate decision to withdraw the trial at this time.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-28